Samil Pharmaceutical Co.,Ltd (KRX:000520)

South Korea · Delayed Price · Currency is KRW

7,760.00

+290.00 (3.88%)

Sep 18, 2026, 3:30 PM KST

Market Cap	165.84B -26.9%
Revenue (ttm)	207.33B -4.5%
Net Income	-37.61B
EPS	-1,767.93
Shares Out	21.37M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	155,813
Open	7,470.00
Previous Close	7,470.00
Day's Range	7,310.00 - 7,860.00
52-Week Range	5,500.00 - 12,860.00
Beta	0.34
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About KRX:000520

Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of pharmaceuticals in South Korea. It offers general medicines, including Tiersil Once, EYE2O mini eye drops, and Optagent ophthalmic drops; medical devices; secret spotpatch quasi-drugs, and roll away products. The company also provides specialty medicines, such as Hycell solutions; Curelen, Ocufridine, Ocumetholone, Ocucyclo, Ocuhomapine, Ocucarpine, Allerfen, Optanac, Forus, Eymox, Cifex, and Ocuracin ophthalmic drops; and Herpecid, Forus, and Ocurasin ophthalmic ointments. Sam... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1947

Employees 583

Stock Exchange Korea Stock Exchange

Ticker Symbol 000520

Full Company Profile

Financial Performance

In 2025, KRX:000520's revenue was 210.25 billion, a decrease of -4.30% compared to the previous year's 219.70 billion. Losses were -34.66 billion, 515.8% more than in 2024.

Financial Statements